click & collect
Collect your order in-store R15 or FREE for orders over R150
Feminesse Menopause And Cardiovascular Support 30 Tablets helps with the symptoms of menopause, like hot flushes, night sweat, headaches, mood swings and vaginal atrophy. Also helps maintain healthy cholesterol.
Feminesse MENO-CalMag Tablets 30
Non-oestrogenic menopause and cardiovascular support. Manufactured and packed under pharmaceutical control in South Africa. Email: [email protected] www.cholesterex.co.za. Patient information leaflet: What you need to know about Feminesse® and Feminesse® Meno-CalMag: Please read this leaflet carefully before you start using this product. Keep this leaflet with your tablets as you may need to read it again. If you have any further questions, please ask your doctor or pharmacist. Scheduling status: SO. Feminesse® is a schedule 0 medicine which means it can be sold without a prescription. Proprietary name and dosage form: There are two types of Feminesse® products available, Feminesse® 30 tablets and Feminesse® Meno-CalMag® 30 tablets. What Feminesse® and Feminesse® Meno-CalMag are used for: Feminesse® and Feminesse® Meno-CalMag are both used for managing vasomotor menopause symptoms. Feminesse® is specifically for those who need to maintain a healthy cholesterol level and Feminesse® Meno-CalMag is for women who need additional calcium for maintaining bone strength. Presentation: Feminesse® and Feminesse® Meno-CalMag tablets are available in packs of 30 tablets. Identification: Feminesse® is a brown bevelled edge scored round tablet. Feminesse® Meno-CalMag is a pink bevelled edge film coated oval tablet. Registration numbers: Feminesse® tablets: to be allocated. Feminesse® Meno-CalMag: to be allocated. Date of publication of this patient information leaflet: January 2014. * %RDA not established. Scheduling status: N/A. Composition: each Feminesse® tablet contains: 80 mg black cohosh extract (root and rhizome extract containing 2 mg triterpine glycosides), 5 mg policosanol and 400 mcg folic acid. Pharmacological classification: A34: other Pharmacological action: N/A. Indications: Feminesse® is indicated to help support the cardiovascular system, the vasomotor imbalances and the physiological changes in the peri-menopausal, menopausal and post-menopausal woman without producing oestrogenic like side effects. (1,2,3,4,5). Contra-indications: Feminesse® is contra-indicated in pregnant and lactating women(3). Conditions of registration: N/A. Identification: flat beveled scored small slow release brown circular tablet. Presentation: packs of 30 tablets in 125ml white plastic product labeled bottle with pressure sealed white plastic top. References: 1. Pons, P et al. Effects of successive dose increases of policosanol on the lipid profile of patients with type 11 hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res. 1994;14(l):27-33. 2. McKenna, DJ et al. Black Cohosh: efficacy, safety and its use in clinical and preclinical applications. Altern Ther Health Med. 2001;7(3): 93-100. 3. Zierau O, et al. Anti-estrogenic activities of Cimicifuga racemosa extracts. J. Steroid Biochem Mol Biol 2002; 80(l):125-30. 4. Liske, E et al. Physiological investigation of a unique extract of Black Cohosh (Cimicifuga racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect J.Woman's Health Gend. Based Med. 2002:11(2): 163-74 5. Liske, E. Therapeutic efficacy and safety of Cimicifuga racemosa for gyneacologic disorders. Adv Ther. 1998;15(l):45-53. 6. Torre, O et al. Treatment of hypercholesterolaemia in NIDDM with Policosanol. Diabetes Care. 1995; 18(3)393-97. 7. Davis, FA. Black Cohosh. 2002. 8. Tesch, BD. Black Cohosh may reduce menopausal symptons. 2001, Medical College of Wisconsin. www.healthlink.mew.edu/article. Email: [email protected] Website: www.rejuvenesse.com. www.cholesterex.co.za. http://tripod.feminesse.com.
Quantity in pack:
Menopause and cardiovascular support. Feminesse®. 80 mg black cohosh; 5 mg policosanol; 400 mcg folic acid. Rejuvenesse®. Assists with: Hot flushes, night sweats. Mood fluctuations, headaches. Vaginal atrophy. Healthy cholesterol levels. 30 tablets.
Dosage and directions for use: Adults: one tablet at night with fluid after a meal. How to take Feminesse® and Feminesse® Meno-CalMag: One tablet at night with fluid, after the evening meal. Do not exceed the recommended dose without consulting your healthcare practitioner. Storage and disposal instructions: Store at room temperature (below 25 degrees C). Keep out of reach of children. Take unused or expired product to your doctor, pharmacist or other health care professional for safe disposal. Dosage and directions for use: one tablet at night, with fluid, after the evening meal.
What Feminesse® and Feminesse® Meno-CalMag contains: Each Feminesse® tablet contains: Black Cohosh 80 mg (main active ingredient). Other ingredients: Policosanol 5 mg; Folic Acid; Vitamin B12. Black Cohosh 80 mg (main active ingredient). Other ingredients are: Calcium carbonate, Folic acid, Vitamin D3, Magnesium, Zinc, Copper.